75 related articles for article (PubMed ID: 1345113)
1. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
Zemelman R; Vejar C; Bello H; Domínguez M; González G
Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
[TBL] [Abstract][Full Text] [Related]
2. 4-Quinolone bactericidal mechanisms.
Howard BM; Pinney RJ; Smith JT
Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of and resistance to ciprofloxacin.
Hooper DC; Wolfson JS; Ng EY; Swartz MN
Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
5. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Jan; 34(1):19-22. PubMed ID: 1703579
[TBL] [Abstract][Full Text] [Related]
6. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
Lewin CS; Amyes SG
J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
8. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
Parte AC; Smith JT
Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
[TBL] [Abstract][Full Text] [Related]
9. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.
Wickens HJ; Pinney RJ
Int J Pharm; 2001 Oct; 227(1-2):149-56. PubMed ID: 11564549
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
DeRyke CA; Kuti JL; Nicolau DP
Pharmacotherapy; 2007 Mar; 27(3):333-42. PubMed ID: 17316145
[TBL] [Abstract][Full Text] [Related]
13. Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
Wojnicz D; Cisowska A
Int J Antimicrob Agents; 2009 Jun; 33(6):579-82. PubMed ID: 19232480
[TBL] [Abstract][Full Text] [Related]
14. [Ciprofloxacin resistance in gram negative bacilli. Epidemiologic aspects].
Martínez-Martínez L; Suárez AI; Carranza R; Perea EJ
Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):474-8. PubMed ID: 8305553
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal mechanisms of ofloxacin.
Lewin CS; Smith JT
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():1-8. PubMed ID: 3053574
[TBL] [Abstract][Full Text] [Related]
16. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile].
Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L
Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ciprofloxacin in stationary-phase bacteria in vivo.
Zeiler HJ; Voigt WH
Am J Med; 1987 Apr; 82(4A):87-90. PubMed ID: 3107381
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity to blood bactericidal activity and hydrophobicity of Acinetobacter baumannii after treatment with imipenem].
Hostacká A
Epidemiol Mikrobiol Imunol; 1999 Apr; 48(2):67-70. PubMed ID: 10349782
[TBL] [Abstract][Full Text] [Related]
20. Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
Howard BM; Pinney RJ; Smith JT
Microbios; 1993; 75(304):185-95. PubMed ID: 8246811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
